Companies: 10,795·Total market cap: $144.5T
Agilon Health, Inc.

Agilon Health, Inc.

AGLNYSEHealthcare● Active
$96.85
+$1.62(+1.70%)
Market Cap$1.6B
P/E Ratio
52W High$99.135
52W Low$7.48
Overview

Agilon Health, Inc. (AGL) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

AGL · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$285.1M -29.7% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$173.7M
cashAndCashEquivalents
Short-Term Investments
$111.4M
shortTermInvestments
YoY Change vs Prior Year
-29.7%
vs prior fiscal year
Latest Quarter
$231.4M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$285.1MCash on Hand
Total Debt$36.8MTotal Debt
Net Cash / Net Debt+$248.3MNet Cash Position
Cash vs Debt Ratio
Cash 89%Debt 11%

Agilon Health, Inc. has a net cash position of $248.3M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$285.1M$36.8M = +$248.3M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
AGL annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$285.1M-29.7%
Dec 31, 2024$405.6M-18.1%
Dec 31, 2023$495.1M-43.6%
Dec 31, 2022$877.2M-16.8%
Dec 31, 2021$1.05B+887.7%
AGL cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Agilon Health, Inc.
Agilon Health, Inc.YOU
AGL
$285.1M17.6%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Agilon Health, Inc. (AGL) cash on hand as of December 31, 2025 is $285.1M, comprising $173.7M in cash and cash equivalents (CCE) plus $111.4M in short-term investments — reported as Agilon Health, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Agilon Health, Inc. cash reserves or cash position.

Agilon Health, Inc. annual cash on hand history shows decreased -29.7% in 2025: decreased -29.7% in 2025. Agilon Health, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Agilon Health, Inc. carries total debt of $36.8M against cash of $285.1M, resulting in a net cash position of +$248.3M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

AGL cash on hand · 5 questions

As of December 31, 2025, Agilon Health, Inc. (AGL) has $285,142,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $173,713,000 in cash and cash equivalents (CCE) plus $111,429,000 in short-term investments. Latest quarter (March 31, 2026): $231,411,000. Data sourced from the annual 10-K filing via FMP.

AGL cash on handAGL cash reservesAGL cash 2025how much cash does AGL have

Source: FMP /balance-sheet-statement · US GAAP · Agilon Health, Inc. · Agilon Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025